top of page

About The Lancet Group

The best science for better lives

The Lancet began as an independent, international weekly general medical journal founded in 1823 by Thomas Wakley. Since its first issue (Oct 5, 1823), the journal has strived to make science widely available so that medicine can serve and transform society, and positively impact the lives of people. 

Over the past two centuries, The Lancet has sought to address urgent topics in our society, initiate debate, put science into context, and influence decision makers around the world. 

The Lancet has evolved as a family of journals but retains at its core the belief that medicine must serve society, that knowledge must transform society, that the best science must lead to better lives. 

Explore the Lancet journals

The Lancet

The Lancet Child & Adolescent Health

The Lancet Diabetes & Endocrinology

The Lancet Digital Health

The Lancet Gastroenterology & Hepatology

The Lancet Global Health

The Lancet Haematology

The Lancet Healthy Longevity

The Lancet HIV

The Lancet Infectious Diseases

The Lancet Microbe

The Lancet Neurology

The Lancet Oncology

The Lancet Planetary Health

The Lancet Psychiatry

The Lancet Public Health

The Lancet Regional Health – Americas

The Lancet Regional Health – Europe

The Lancet Regional Health – Southeast Asia

The Lancet Regional Health – Western Pacific

The Lancet Respiratory Medicine

The Lancet Rheumatology

eBioMedicine

eClinicalMedicine

Our manifesto

Highest standards for medical science
 

The Lancet sets extremely high standards. We select only the best research papers for their quality of work and the progression they bring.

Improving lives is the only end goal
 

Too much research is done for research’s sake. We believe that improving lives is the only end goal and that research is only relevant when it has impact on human lives.

Increasing the social impact of science
 

We recognise that a great research paper is not enough and that it requires development, mobilisation, and exposure. So we promise to set agendas, create context, inform leaders, start debates, and advocate for the idea that research can and will make a difference.

A commitment to publishing excellence

  • Publishing excellence: as trusted sources of information, the Lancet journals set extremely high standards for publishing, and we are committed to ensuring that our editorial processes meet our standards of excellence. Read our editorial policies.

  • Journey of a paper: from peer review, through our in-house editing process, production, to publication and beyond, the entire Lancet team brings a wealth of expertise in scholarly publishing. Follow the journey of a paper.

  • Peer review: peer review plays a vital role in ensuring the integrity of the scientific record. Our community of authors and external peer reviewers work in partnership with our expert editors to publish the best science to advance the health and wellbeing of people worldwide. Find out more about peer review at The Lancet Group.

Reach and impact

The Lancet journals are both a destination for publication and a platform to advance the global impact of research. The Lancet Group cares that your work is highly visible to a global network of researchers, clinicians, industry professionals, policy makers, media outlets, patients, and the wider public, and we work with you and your affiliated institutions to maximise the impact of your research on the world.

  • Lancet journals have extensive global reach with more than 36·6 million annual visits and 108·1 million downloaded articles across TheLancet.com and ScienceDirect.

  • Lancet Alerts, including our electronic Table of Contents, have over 3·9 million subscribers.

  • Lancet journals have nearly 2·8 million followers on  X (formerly Twitter), FacebookLinkedInInstagramWeChatWeiboLittle red book, and YouTube.

  • With over 180 000 annual mentions in news articles, research published in Lancet journals receives regular coverage in influential media such as the Associated Press, BBC, CNN, Financial Times, The Guardian, The New York Times, NPR, and The Washington Post.

  • Lancet podcasts receive over 85 000 listens each month.

  • Lancet Webinars have been viewed more than 6500 times by audiences in 161 countries, and the Lancet Webinars | China have been viewed more than 174 000 times by audiences in China.

Our journals are internationally trusted sources of clinical, public health, and global health knowledge. We recognise that the Journal Impact Factor is just one measure of a journal's performance and encourage you to explore additional journal impact metrics, which provide a means to further assess our journals. 

 

Discover more

What is The Lancet?

The Lancet: What we publish, and why

Our global team

We are a collaborative, international team of over 170 professional editors, technical copy editors, production editors, marketing and communications specialists, designers, publishers, operations managers, editorial assistants, and multimedia and digital experts all dedicated to advancing health worldwide. Our main office is in London (UK), and we have offices in Beijing (China), New York (USA), Munich (Germany) as well as teams in Amsterdam (Netherlands), Barcelona (Spain), Cambridge (USA), Chennai (India), Madrid (Spain), Oxford (UK), Philadelphia (USA), Rio de Janeiro (Brazil), Shanghai (China), Sydney (Australia), and South Africa.

Meet our team

 

CLINICAL INITIATIVES

GLOBAL HEALTH INITIATIVES

MULTIMEDIA

Information

Access

Connect

  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube

AFCNS@

USA FEDERAL REGISTRATION NUMBER: 33-2279784.  AMFCM - 33-1380947.

501(c)(3) organization

Donations are tax-deductible

532 RIDING MEADOW RD

PITTSBURGH PA 15238-1937

PITTSBURGH PA | IRS ruling year: 1978 | EIN: 25-1347717.

525 Twenty-third Street, N.W. Washington, D.C. 20037, U.S.A.  EIN: 75-3215103.

501(c)(3) organization

Donations are tax-deductible

WORLD ACCESS HEALTH ORGANIZATION

501(c)(3) organization

Donations are tax-deductible

8465 INDIAN PAINTBRUSH WAY

Lorton VA 22079-5610

Mail donations to:8465 INDIAN PAINTBRUSH WAYLORTON VA 22079-5610

Lorton VA | IRS ruling year: 2019 | EIN: 45-2755067.  

bottom of page